People with autoimmune diseases often have more than one long-lasting pain condition, so MS patients should watch for and treat overlapping pains together, not separately.
Researchers looked at health insurance records for people with autoimmune rheumatic diseases and found that more than half had at least one long-term pain condition, and nearly one in four had several at the same time. The most common pains were long-term low back pain (like a constant ache in the lower back) and fibromyalgia (widespread pain with tiredness and sensitivity). Women and people aged about 31–50 were more likely to have these overlapping pain problems. Some pain conditions tended to appear together more often than expected, for example low back pain with fibromyalgia or migraine, suggesting they might share common causes or triggers. The authors recommend regular screening for multiple pain types and using non-opioid, mixed approaches (like exercise, education, and some medicines) that target several pain problems at once.
People with MS and their caregivers should care because MS is an autoimmune condition too, and having more than one chronic pain can make daily life harder, like feeling tired sooner or moving less. Think of pain types like several small leaks in a roof: fixing only one leak won’t stop the house from getting wet; treating all leaks together works better. Healthcare providers should know to ask about different kinds of pain, not just the most obvious one, because combined treatments may help more and lower the need for opioids. Caregivers can help by tracking different pain types and patterns (for example, noting when headaches and back pain happen together) to share with the care team. The people who benefit most are MS patients who have more than one pain, their families who support daily activities, and clinicians planning safer, broader pain care.
This study used insurance billing records, which show diagnoses but not full clinical details like pain severity or exact causes, so results may miss some cases or details. The research looked at people with rheumatic autoimmune diseases, not MS specifically, so we cannot assume the exact numbers apply to all MS patients, though the idea of overlapping pains is likely relevant. The study can show links (that pains often occur together) but cannot prove one pain causes another or identify the exact biological reason.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More6/1/2026
Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n
Read More5/19/2026
Study finds immune protein C4 is made in certain white blood cells and linked to gene copies; this o
Read More5/18/2026
Stronger, clearer research rules and better patient choices can make studies on post-treatment Lyme,
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Arthritis care & research often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.